Single-cell RNA sequencing reveals the molecular features of peripheral blood immune cells in children, adults and centenarians

Front Immunol. 2023 Jan 10:13:1081889. doi: 10.3389/fimmu.2022.1081889. eCollection 2022.

Abstract

Peripheral blood immune cells have different molecular characteristics at different stages of the whole lifespan. Knowledge of circulating immune cell types and states from children to centenarians remains incomplete. We profiled peripheral blood mononuclear cells (PBMCs) of multiple age groups with single-cell RNA sequencing (scRNA-seq), involving the age ranges of 1-12 (G1), 20-30(G2), 30-60(G3), 60-80(G4), and >110 years (G5). The proportion and states of myeloid cells change significantly from G1 to G2. We identified a novel CD8+CCR7+GZMB+ cytotoxic T cell subtype specific in G1, expressing naive and cytotoxic genes, and validated by flow cytometry. CD8+ T cells showed significant changes in the early stage (G1 to G2), while CD4+ T cells changed in the late stage (G4 to G5). Moreover, the intercellular crosstalk among PBMCs in G1 is very dynamic. Susceptibility genes for a variety of autoimmune diseases (AIDs) have different cell-specific expression localization, and the expression of susceptibility genes for AIDs changes with age. Notably, the CD3+ undefined T cells clearly expressed susceptibility genes for multiple AIDs, especially in G3. ETS1 and FLI1, susceptibility genes associated with systemic lupus erythematosus, were differentially expressed in CD4+ and CD8+ effector cells in G1 and G3. These results provided a valuable basis for future research on the unique immune system of the whole lifespan and AIDs.

Keywords: CD8+ cytotoxic T cells; autoimmune diseases; peripheral blood mononuclear cells; single-cell RNA sequencing (scRNAseq); whole lifespan.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged, 80 and over
  • Antineoplastic Agents*
  • Autoimmune Diseases* / metabolism
  • CD8-Positive T-Lymphocytes
  • Centenarians
  • Child
  • Humans
  • Leukocytes, Mononuclear
  • Sequence Analysis, RNA

Substances

  • Antineoplastic Agents

Grants and funding

This research was funded by National Natural Science Foundation of China (82170720) and Chongqing Municipal Education Commission (KJZD-M201900401).